Therefore, the understanding of molecular and genetic mechanisms that control Lcn-2 signaling and recycling of iron could offer new perspectives for future therapeutic avenues in acute kidney injury and progressive interstitial fibrosis. This evidence concerns the gene LCN2 and acute kidney injury.